Stockreport

Selecta Biosciences Says FDA Puts Clinical Hold on SEL-302 Trial, Shares Lower [MarketWatch]

Selecta Biosciences, Inc.  (SELB) 
Last selecta biosciences, inc. earnings: 3/12 08:00 am Check Earnings Report
PDF Food and Drug Administration placed a clinical hold on its Phase 1/2 clinical trial of SEL-302 to treat patients with methylmalonic acidemia. The company said SEL-302 [Read more]